Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease
Clinical trial NCT04040894 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04040894
- Sponsor
- Amgen
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.